Acetazolamide on REM OSA

计划入组 11 人 · 首次发布于 2022 年 10 月 21 日

Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma

计划入组 125 人 · 首次发布于 2023 年 11 月 7 日

REM (Risk Of Endometrial Malignancy)

计划入组 741 人 · 首次发布于 2013 年 4 月 12 日

OSA-8302

OSA-102

REM-1086 Prodrugs (Rel-MD)

Kintara Therapeutics

United States

OUTCOME REA

France

Cem Demirel

Germany

Umbilical Cord Blood Biomarkers UCH-L1 and GFAP Reveal Fetal Neural Stress in Maternal Sleep-Disordered Breathing

AD109 Advances to Phase III Trials as First Oral Therapy for Obstructive Sleep Apnea

Kintara Therapeutics Announces Corporate Updates and REM-001 Clinical Study Progress